News Image

Should you consider BLUE BIRD CORP (NASDAQ:BLBD) for growth investing?

By Mill Chart

Last update: Apr 17, 2024

In this article we will dive into BLUE BIRD CORP (NASDAQ:BLBD) as a possible candidate for growth investing. Investors should always do their own research, but we noticed BLUE BIRD CORP showing up in our Louis Navellier growth screen, which makes it worth to investigate a bit more.

Exploring Why NASDAQ:BLBD Holds Promise for Growth Investors.

  • BLUE BIRD CORP exhibits a strong Return on Equity (ROE) of 81.07%, indicating the company's ability to generate solid returns on shareholder investments. This metric reflects the company's efficient utilization of equity capital and its profitability.
  • BLUE BIRD CORP has consistently exceeded EPS estimates in the last 4 quarters, demonstrating its ability to outperform market expectations. This trend highlights the company's strong financial performance and its potential for future growth.
  • With notable 1-year revenue growth of 33.9%, BLUE BIRD CORP exemplifies its ability to generate increased sales and revenue streams. This growth signifies the company's strong business performance and its potential for future growth.
  • BLUE BIRD CORP has demonstrated strong quarter-to-quarter (Q2Q) revenue growth of 34.77%, reflecting its ability to generate consistent increases in sales. This growth highlights the company's effective market positioning and its potential for continued success.
  • BLUE BIRD CORP has experienced notable growth in its operating margin over the past year, reflecting improved operational performance. This growth suggests the company's ability to generate higher profits from its core business activities.
  • With a favorable trend in its free cash flow (FCF) over the past year, BLUE BIRD CORP demonstrates its ability to generate robust cash flows and maintain financial stability. This growth reflects the company's focus on efficient capital allocation and cash management.
  • The EPS of BLUE BIRD CORP has exhibited growth from one quarter to another (Q2Q), with a 403.0% increase. This underscores the company's ability to generate higher earnings and improve its financial standing.
  • Over the past 3 months, analysts have adjusted their EPS Estimate for BLUE BIRD CORP with a 51.56% change. This highlights the evolving outlook on the company's EPS potential.
  • The recent financial report of BLUE BIRD CORP demonstrates a 403.0% increase in quarterly earnings compared to the previous quarter. This growth indicates positive momentum in the company's financials and suggests a promising upward trend
  • The earnings per share (EPS) growth of BLUE BIRD CORP are accelerating: the current Q2Q growth of 403.0% is above the previous year Q2Q growth of -329.0%. Earnings momentum and acceleration are key for high growth systems.

Zooming in on the fundamentals.

Every day ChartMill assigns a Fundamental Rating to every stock. The score ranges from 0 to 10 and is determined by evaluating multiple fundamental indicators and properties.

BLBD gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 131 industry peers in the Machinery industry. Both the profitability and the financial health of BLBD get a neutral evaluation. Nothing too spectacular is happening here. BLBD has both an excellent growth and valuation score. This means it is growing and it is still cheap. This is a rare combination! With these ratings, BLBD could be worth investigating further for value and growth investing!.

Check the latest full fundamental report of BLBD for a complete fundamental analysis.

More ideas for growth investing can be found on ChartMill in our Lois Navellier screen.

Keep in mind

This article should in no way be interpreted as advice in any way. The article is based on the observed metrics at the time of writing, but you should always make your own analysis and trade or invest at your own responsibility.

Back

BLUE BIRD CORP

NASDAQ:BLBD (4/29/2024, 7:00:01 PM)

After market: 34.52 0 (0%)

34.52

+0.55 (+1.62%)

BLBD News

News Image7 hours ago - InvestorPlace3 Obscure Stocks That Could Revolutionize Your Returns

Investors mostly pay close attention to popular stocks. But, there are also strong stocks with low trading volume available.

News Image5 days ago - Blue Bird CorporationBlue Bird to Report Fiscal 2024 Second Quarter Results on May 8, 2024
News Image13 days ago - ChartmillShould you consider BLUE BIRD CORP (NASDAQ:BLBD) for growth investing?

Why the growth investor may take a look at BLUE BIRD CORP (NASDAQ:BLBD).

News Image14 days ago - ChartmillLooking for growth without the hefty price tag? Consider NASDAQ:BLBD.

While growth is established for BLUE BIRD CORP (NASDAQ:BLBD), the stock's valuation remains reasonable.

News Image20 days ago - InvestorPlaceAhead of the Curve: 7 Stocks to Buy Before They Go Mainstream

Discover seven overlooked stocks to buy poised for 10X returns across diverse industries. Unlock their growth potential now.

News Imagea month ago - InvestorPlace7 EV Stocks That Could Be Multibaggers in the Making: March Edition

Discover EV stocks poised for explosive growth, tapping into cutting-edge technology and market dominance.

News Imagea month ago - InvestorPlace3 Promising Small-Cap Stocks Packing a Powerful Punch

Here're three under-the-radar small-cap stocks with robust growth potential that could deliver outsized returns for risk-tolerant investors.

News Image2 months ago - InvestorPlaceBeat Wall Street: 3 Stocks Flying Under the Radar

The market is full of many companies that most people haven’t even heard of. Add these stocks to your portfolio that fly under the radar.

News Image2 months ago - InvestorPlace7 Must-Buy Stocks for a Diversified High-Growth Portfolio

Explore how these high-growth portfolio stocks can drive substantial returns in IT, communication, industrials, and financials.

News Image2 months ago - NewsfileAdaptimmune Hires Chief Commercial Officer in Advance of Q3 2024 PDUFA Date for Afami-cel, a Late-stage Product in the Company's Sarcoma Franchise

Philadelphia, Pennsylvania and Oxford, United Kingdom--(Newsfile Corp. - February 27, 2024) - Adaptimmune Therapeutics plc (NASDAQ: ADAP), a company redefining...

News Image2 months ago - InvestorPlaceWall Street Favorites: 3 EV Stocks With Strong Buy Ratings for February 2024

Though the certainty of the electric vehicle industry may be waning, these three EV stocks offer strong potential nonetheless.

News Image2 months ago - InvestorPlace3 Goliath Growth Stocks Poised for Takeoff in February

These three top-tier growth stocks to buy offer investors incredible potential returns and are perfect for long-term investing.

BLBD Links
Follow us for more